These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 22082586

  • 1. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ, Greenhough A, Ordóñez-Morán P, Talero E, Cherry CA, Wallam CA, Parry L, Al Kharusi M, Roberts HR, Mariadason JM, Clarke AR, Huelsken J, Williams AC, Paraskeva C.
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [Abstract] [Full Text] [Related]

  • 2. β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?
    Smartt HJ, Greenhough A, Ordóñez-Morán P, Al-Kharusi M, Collard TJ, Mariadason JM, Huelsken J, Williams AC, Paraskeva C.
    Br J Cancer; 2012 Oct 23; 107(9):1514-7. PubMed ID: 23033009
    [Abstract] [Full Text] [Related]

  • 3. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC, Paraskeva C.
    Carcinogenesis; 2009 Oct 23; 30(10):1796-804. PubMed ID: 19638428
    [Abstract] [Full Text] [Related]

  • 4. 15-hydroxyprostaglandin dehydrogenase in colorectal mucosa as a potential biomarker for predicting colorectal neoplasms.
    Lee HJ, Yang DH, Ryu YM, Song M, Song HJ, Jung KW, Kim KJ, Ye BD, Byeon JS, Choi EK, Yang SK, Kim JH, Myung SJ.
    J Korean Med Sci; 2013 Aug 23; 28(8):1154-60. PubMed ID: 23960441
    [Abstract] [Full Text] [Related]

  • 5. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A, Ganesan A, Mrena J, Junnila S, Nykänen A, Hemmes A, Tai HH, Monni O, Kokkola A, Haglund C, Petrova TV, Ristimäki A.
    Clin Cancer Res; 2009 Jul 15; 15(14):4572-80. PubMed ID: 19584167
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.
    Kim HB, Kim M, Park YS, Park I, Kim T, Yang SY, Cho CJ, Hwang D, Jung JH, Markowitz SD, Hwang SW, Yang SK, Lim DS, Myung SJ.
    Gastroenterology; 2017 Feb 15; 152(3):616-630. PubMed ID: 27864128
    [Abstract] [Full Text] [Related]

  • 7. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
    Mann JR, Backlund MG, Buchanan FG, Daikoku T, Holla VR, Rosenberg DW, Dey SK, DuBois RN.
    Cancer Res; 2006 Jul 01; 66(13):6649-56. PubMed ID: 16818638
    [Abstract] [Full Text] [Related]

  • 8. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb 01; 290(2):G361-8. PubMed ID: 16195422
    [Abstract] [Full Text] [Related]

  • 9. 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.
    Pham H, Eibl G, Vincenti R, Chong B, Tai HH, Slice LW.
    Mol Carcinog; 2008 Jun 01; 47(6):466-77. PubMed ID: 18058808
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN, Kusmartsev SA, Krendelchtchikova V, Stockard CR, Grizzle WE, Buchsbaum DJ, Kaliberov SA.
    Mol Cancer Ther; 2009 Nov 01; 8(11):3130-9. PubMed ID: 19887544
    [Abstract] [Full Text] [Related]

  • 12. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
    Fink SP, Yamauchi M, Nishihara R, Jung S, Kuchiba A, Wu K, Cho E, Giovannucci E, Fuchs CS, Ogino S, Markowitz SD, Chan AT.
    Sci Transl Med; 2014 Apr 23; 6(233):233re2. PubMed ID: 24760190
    [Abstract] [Full Text] [Related]

  • 13. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
    Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL, Katkuri S, DuBois RN.
    J Biol Chem; 2005 Feb 04; 280(5):3217-23. PubMed ID: 15542609
    [Abstract] [Full Text] [Related]

  • 14. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
    Monteleone NJ, Moore AE, Iacona JR, Lutz CS, Dixon DA.
    Sci Rep; 2019 Apr 01; 9(1):5405. PubMed ID: 30931980
    [Abstract] [Full Text] [Related]

  • 15. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Zhang C, Huang B, Hu ZW.
    Gastroenterology; 2019 Feb 01; 156(3):708-721.e15. PubMed ID: 30365932
    [Abstract] [Full Text] [Related]

  • 16. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
    Dai L, King DW, Perera DS, Lubowski DZ, Burcher E, Liu L.
    Dig Dis Sci; 2015 May 01; 60(5):1236-46. PubMed ID: 25666316
    [Abstract] [Full Text] [Related]

  • 17. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
    Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD.
    Proc Natl Acad Sci U S A; 2004 Dec 14; 101(50):17468-73. PubMed ID: 15574495
    [Abstract] [Full Text] [Related]

  • 18. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.
    Liu Y, Borchert GL, Surazynski A, Phang JM.
    Oncogene; 2008 Dec 04; 27(53):6729-37. PubMed ID: 18794809
    [Abstract] [Full Text] [Related]

  • 19. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.
    Gastroenterology; 2014 Aug 04; 147(2):430-442.e8. PubMed ID: 24846398
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH.
    Cancer Metastasis Rev; 2011 Dec 04; 30(3-4):409-17. PubMed ID: 22020925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.